Who is sponsoring NCT02099682?

NCT02099682 is sponsored by Takeda.

What condition does NCT02099682 study?

NCT02099682 studies Gastric or Duodenal Ulcers.

What is the status of NCT02099682?

NCT02099682 is currently COMPLETED.

Last reviewed 2016-09-23 · How we verify

Takepron Capsules 15/ Orally Dispersing (OD) Tablets 15 Special Drug Use Surveillance Long-term Use Survey on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin

NCT02099682 COMPLETED Results posted

The purpose of this study is to investigate the safety and efficacy of long-term administration of lansoprazole (Takepron) for up to 12 months in the routine clinical setting in patients receiving low-dose aspirin

Details

Lead sponsor	Takeda
Status	COMPLETED
Enrolment	3366
Start date	2010-08
Completion	2014-01

Conditions

Gastric or Duodenal Ulcers

Interventions

Lansoprazole

Primary outcomes

Frequency of Adverse Drug Reactions — 12 months
Frequency, severity, and time to onset of adverse drug reactions tabulated by each symptom. Adverse events are defined as any unfavorable and unintended signs, symptoms or diseases temporally associated with the use of a medicinal product reported from the first dose of study drug to the last dose of study drug. Among these, events which are considered possibly associated with a medicinal product are defined as adverse drug reactions.